This company listing is no longer active
IMV Crecimiento futuro
Future controles de criterios 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for IMV.
Información clave
17.6%
Tasa de crecimiento de los beneficios
30.7%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Biotechs | 37.1% |
| Tasa de crecimiento de los ingresos | 58.3% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 02 May 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2025 | 3 | -43 | -43 | -44 | 2 |
| 12/31/2024 | 3 | -39 | -42 | -43 | 2 |
| 12/31/2022 | N/A | -38 | -34 | -33 | N/A |
| 9/30/2022 | N/A | -41 | -36 | -35 | N/A |
| 6/30/2022 | N/A | -43 | -36 | -34 | N/A |
| 3/31/2022 | N/A | -40 | -35 | -34 | N/A |
| 12/31/2021 | N/A | -37 | -33 | -32 | N/A |
| 9/30/2021 | 0 | -32 | -28 | -28 | N/A |
| 6/30/2021 | 0 | -28 | -23 | -23 | N/A |
| 3/31/2021 | 0 | -26 | -26 | -26 | N/A |
| 12/31/2020 | N/A | -26 | -24 | -23 | N/A |
| 9/30/2020 | 0 | -25 | -26 | -26 | N/A |
| 6/30/2020 | 0 | -24 | -25 | -25 | N/A |
| 3/31/2020 | 0 | -22 | -19 | -19 | N/A |
| 12/31/2019 | 0 | -21 | -21 | -21 | N/A |
| 9/30/2019 | 0 | -20 | -20 | -19 | N/A |
| 6/30/2019 | 0 | -19 | -20 | -19 | N/A |
| 3/31/2019 | 0 | -19 | -18 | -16 | N/A |
| 12/31/2018 | 0 | -16 | -14 | -13 | N/A |
| 9/30/2018 | 0 | -15 | -13 | -11 | N/A |
| 6/30/2018 | 0 | -12 | -10 | -9 | N/A |
| 3/31/2018 | 0 | -10 | -9 | -8 | N/A |
| 12/31/2017 | 0 | -10 | -7 | -7 | N/A |
| 9/30/2017 | N/A | -9 | -7 | -7 | N/A |
| 6/30/2017 | N/A | -8 | -5 | -5 | N/A |
| 3/31/2017 | 0 | -7 | -5 | -5 | N/A |
| 12/31/2016 | 0 | -7 | -5 | -5 | N/A |
| 9/30/2016 | 0 | -6 | N/A | -4 | N/A |
| 6/30/2016 | 0 | -6 | N/A | -5 | N/A |
| 3/31/2016 | 0 | -7 | N/A | -5 | N/A |
| 12/31/2015 | 0 | -6 | N/A | -5 | N/A |
| 9/30/2015 | 0 | -6 | N/A | -6 | N/A |
| 6/30/2015 | N/A | -6 | N/A | -5 | N/A |
| 3/31/2015 | N/A | -5 | N/A | -4 | N/A |
| 12/31/2014 | N/A | -6 | N/A | -4 | N/A |
| 9/30/2014 | N/A | -5 | N/A | -4 | N/A |
| 6/30/2014 | N/A | -5 | N/A | -5 | N/A |
| 3/31/2014 | N/A | -5 | N/A | -5 | N/A |
| 12/31/2013 | N/A | -4 | N/A | -4 | N/A |
| 9/30/2013 | N/A | -5 | N/A | -5 | N/A |
| 6/30/2013 | N/A | -6 | N/A | -5 | N/A |
| 3/31/2013 | N/A | -6 | N/A | -5 | N/A |
| 12/31/2012 | N/A | -6 | N/A | -6 | N/A |
| 9/30/2012 | N/A | -6 | N/A | -3 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: IMV is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: IMV is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: IMV is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: IMV's revenue (58.3% per year) is forecast to grow faster than the Canadian market (5.2% per year).
Ingresos de alto crecimiento: IMV's revenue (58.3% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if IMV's Return on Equity is forecast to be high in 3 years time